Keywords: Endo Pharma, HealthTronics, SYNERGO, M&A, Licensing
Endo Pharma to acquire HealthTronics in $233 million deal; plans to gain rights to SYNERGO system
Article | 07 May 2010
Aiming to continue its diversification, moving into new growth areas beyond pharmaceuticals and strengthening its position in urology, USA-based drugmaker ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
